Pomanda estimates the enterprise value of AVENUE PHARMACY (SUNDERLAND) LIMITED at £1.3m based on a Turnover of £3.4m and 0.37x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of AVENUE PHARMACY (SUNDERLAND) LIMITED at £0 based on an EBITDA of £-72.8k and a 4.09x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of AVENUE PHARMACY (SUNDERLAND) LIMITED at £3.6m based on Net Assets of £1.8m and 1.98x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Avenue Pharmacy (sunderland) LimitedOverview
Avenue Pharmacy (sunderland) Limited is a live company located in tyne and wear, SR6 7JW with a Companies House number of 04490888. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in July 2002, it's largest shareholder is
avenue (north east) limited
with a 100% stake. Avenue Pharmacy (sunderland) Limited is a mature,
small sized company, Pomanda has estimated its turnover at
£3.4m with
low
growth in recent years.
Pomanda's financial health check has awarded Avenue Pharmacy (Sunderland) Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 7 areas for improvement. Company Health Check FAQs
Health Rating3out of 5
2 Strong
3 Regular
7 Weak
Size
annual sales of £3.4m, make it smaller than the average company (£12m)
£3.4m - Avenue Pharmacy (sunderland) Limited
£12m - Industry AVG
Growth
3 year (CAGR) sales growth of 4%, show it is growing at a slower rate (7%)
4% - Avenue Pharmacy (sunderland) Limited
7% - Industry AVG
Production
with a gross margin of 32.4%, this company has a comparable cost of product (32.4%)
32.4% - Avenue Pharmacy (sunderland) Limited
32.4% - Industry AVG
Profitability
an operating margin of -4.6% make it less profitable than the average company (3.1%)
-4.6% - Avenue Pharmacy (sunderland) Limited
3.1% - Industry AVG
Employees
with 37 employees, this is below the industry average (74)
37 - Avenue Pharmacy (sunderland) Limited
74 - Industry AVG
Pay Structure
on an average salary of £25.3k, the company has an equivalent pay structure (£25.3k)
£25.3k - Avenue Pharmacy (sunderland) Limited
£25.3k - Industry AVG
Efficiency
resulting in sales per employee of £91.7k, this is less efficient (£144.4k)
£91.7k - Avenue Pharmacy (sunderland) Limited
£144.4k - Industry AVG
Debtor Days
it gets paid by customers after 37 days, this is later than average (30 days)
37 days - Avenue Pharmacy (sunderland) Limited
30 days - Industry AVG
Creditor Days
its suppliers are paid after 37 days, this is quicker than average (64 days)
37 days - Avenue Pharmacy (sunderland) Limited
64 days - Industry AVG
Stock Days
it holds stock equivalent to 39 days, this is in line with average (36 days)
39 days - Avenue Pharmacy (sunderland) Limited
36 days - Industry AVG
Cash Balance
has cash to cover current liabilities
for 85 weeks, this is more cash available to meet short term requirements (15 weeks)
85 weeks - Avenue Pharmacy (sunderland) Limited
15 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 18.1%, this is a lower level of debt than the average (58.2%)
18.1% - Avenue Pharmacy (sunderland) Limited
58.2% - Industry AVG
AVENUE PHARMACY (SUNDERLAND) LIMITED financials
EXPORT
Avenue Pharmacy (Sunderland) Limited's latest turnover from July 2023 is estimated at £3.4 million and the company has net assets of £1.8 million. According to their latest financial statements, Avenue Pharmacy (Sunderland) Limited has 37 employees and maintains cash reserves of £652.6 thousand as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Jul 2023
Jul 2022
Jul 2021
Jul 2020
Jul 2019
Jul 2018
Jul 2017
Jul 2016
Jul 2015
Jul 2014
Jul 2013
Jul 2012
Jul 2011
Jul 2010
Jul 2009
Turnover
3,393,834
3,483,459
3,088,497
3,032,160
3,442,422
3,294,091
3,066,870
3,683,315
3,113,503
4,560,717
3,921,692
2,459,082
2,743,424
2,462,057
Other Income Or Grants
Cost Of Sales
2,293,566
2,316,875
2,080,339
2,091,959
2,357,492
2,229,648
2,068,501
2,496,773
2,178,198
3,159,310
2,692,408
1,733,157
1,931,212
1,715,946
Gross Profit
1,100,268
1,166,583
1,008,158
940,201
1,084,930
1,064,443
998,369
1,186,543
935,305
1,401,407
1,229,284
725,924
812,212
746,111
Admin Expenses
1,256,144
1,398,781
555,213
590,817
1,165,990
1,070,322
899,585
927,274
1,453,311
1,103,436
1,103,403
397,322
813,615
508,108
-1,494,771
Operating Profit
-155,876
-232,198
452,945
349,384
-81,060
-5,879
98,784
259,269
-518,006
297,971
125,881
328,602
-1,403
238,003
1,494,771
Interest Payable
1,229
1,229
2,101
2,101
Interest Receivable
36,449
12,568
1,051
622
2,911
2,296
955
1,703
1,265
642
1,243
1,390
1,444
1,926
1,022
Pre-Tax Profit
-119,427
-219,630
453,996
350,006
-78,149
-3,583
99,738
260,971
-516,741
298,613
125,895
328,763
-2,060
237,828
1,495,793
Tax
-86,259
-66,501
-18,950
-52,194
-62,709
-28,956
-78,903
-66,592
-418,822
Profit After Tax
-119,427
-219,630
367,737
283,505
-78,149
-3,583
80,788
208,777
-516,741
235,904
96,939
249,860
-2,060
171,236
1,076,971
Dividends Paid
Retained Profit
-119,427
-219,630
367,737
283,505
-78,149
-3,583
80,788
208,777
-516,741
235,904
96,939
249,860
-2,060
171,236
1,076,971
Employee Costs
934,604
866,498
775,668
710,472
692,708
345,087
360,130
569,515
470,846
689,143
558,016
319,866
370,497
301,922
Number Of Employees
37
37
35
34
33
17
19
32
27
40
33
19
22
18
EBITDA*
-72,834
-146,788
534,150
432,801
7,401
78,538
186,084
259,269
-422,314
395,672
218,379
417,438
85,350
324,689
1,578,111
* Earnings Before Interest, Tax, Depreciation and Amortisation
Jul 2023
Jul 2022
Jul 2021
Jul 2020
Jul 2019
Jul 2018
Jul 2017
Jul 2016
Jul 2015
Jul 2014
Jul 2013
Jul 2012
Jul 2011
Jul 2010
Jul 2009
Tangible Assets
50,194
55,241
68,592
52,140
69,077
70,968
62,822
78,938
99,825
781,995
716,236
698,993
386,800
298,161
177,707
Intangible Assets
93,551
164,735
235,919
307,103
378,287
449,471
520,655
591,839
663,023
734,207
805,391
876,575
947,759
1,018,943
1,090,127
Investments & Other
Debtors (Due After 1 year)
26,986
16,453
16,453
45,483
97,207
66,166
66,166
46,664
Total Fixed Assets
170,731
236,429
320,964
404,726
544,571
586,605
649,643
717,441
762,848
1,516,202
1,521,627
1,575,568
1,334,559
1,317,104
1,267,834
Stock & work in progress
246,777
266,049
246,753
259,973
198,400
258,100
261,963
316,138
309,407
301,360
305,988
255,314
286,360
227,896
209,268
Trade Debtors
348,610
311,367
285,255
310,301
490,705
552,700
580,270
601,158
386,158
675,333
630,900
337,376
356,499
309,329
330,274
Group Debtors
662,967
691,954
710,420
584,956
147,551
131,657
Misc Debtors
155,798
209,624
142,092
131,486
219,811
137,284
314,686
257,179
99,123
Cash
652,590
805,351
1,205,542
897,346
347,001
429,171
489,403
274,318
406,730
99,280
157,503
339,572
216,325
361,372
408,997
misc current assets
total current assets
2,066,742
2,284,345
2,590,062
2,184,062
1,403,468
1,508,912
1,646,322
1,448,793
1,201,418
1,075,973
1,094,391
932,262
859,184
898,597
948,539
total assets
2,237,473
2,520,774
2,911,026
2,588,788
1,948,039
2,095,517
2,295,965
2,166,234
1,964,266
2,592,175
2,616,018
2,507,830
2,193,743
2,215,701
2,216,373
Bank overdraft
Bank loan
Trade Creditors
234,689
505,757
453,869
495,902
350,208
442,129
453,724
441,453
637,473
658,177
729,363
599,329
688,391
622,435
723,350
Group/Directors Accounts
61,397
54,833
33,480
other short term finances
hp & lease commitments
other current liabilities
160,654
55,007
154,625
135,171
68,351
45,806
173,859
141,614
total current liabilities
395,343
560,764
608,494
631,073
418,559
487,935
688,980
637,900
637,473
691,657
729,363
599,329
688,391
622,435
723,350
loans
37,814
64,660
hp & lease commitments
Accruals and Deferred Income
other liabilities
122,236
146,683
12,975
235,250
319,541
251,054
270,292
408,589
provisions
9,903
8,356
9,012
7,485
9,438
9,391
5,211
7,348
14,584
58,593
58,359
55,039
8,051
10,007
7,363
total long term liabilities
9,903
8,356
131,248
154,168
9,438
9,391
5,211
7,348
14,584
71,568
293,609
412,394
259,105
344,959
415,952
total liabilities
405,246
569,120
739,742
785,241
427,997
497,326
694,191
645,248
652,057
763,225
1,022,972
1,011,723
947,496
967,394
1,139,302
net assets
1,832,227
1,951,654
2,171,284
1,803,547
1,520,042
1,598,191
1,601,774
1,520,986
1,312,209
1,828,950
1,593,046
1,496,107
1,246,247
1,248,307
1,077,071
total shareholders funds
1,832,227
1,951,654
2,171,284
1,803,547
1,520,042
1,598,191
1,601,774
1,520,986
1,312,209
1,828,950
1,593,046
1,496,107
1,246,247
1,248,307
1,077,071
Jul 2023
Jul 2022
Jul 2021
Jul 2020
Jul 2019
Jul 2018
Jul 2017
Jul 2016
Jul 2015
Jul 2014
Jul 2013
Jul 2012
Jul 2011
Jul 2010
Jul 2009
Operating Activities
Operating Profit
-155,876
-232,198
452,945
349,384
-81,060
-5,879
98,784
259,269
-518,006
297,971
125,881
328,602
-1,403
238,003
1,494,771
Depreciation
11,858
14,226
10,021
12,233
17,277
13,233
16,116
24,508
26,517
21,314
17,652
15,569
15,502
12,156
Amortisation
71,184
71,184
71,184
71,184
71,184
71,184
71,184
71,184
71,184
71,184
71,184
71,184
71,184
71,184
Tax
-86,259
-66,501
-18,950
-52,194
-62,709
-28,956
-78,903
-66,592
-418,822
Stock
-19,272
19,296
-13,220
61,573
-59,700
-3,863
-54,175
6,731
8,047
-4,628
50,674
-31,046
58,464
18,628
209,268
Debtors
-35,037
75,178
81,994
116,952
67,467
-73,315
56,121
419,720
-190,052
44,433
293,524
-19,123
47,170
-20,945
330,274
Creditors
-271,068
51,888
-42,033
145,694
-91,921
-11,595
12,271
-196,020
-20,704
-71,186
130,034
-89,062
65,956
-100,915
723,350
Accruals and Deferred Income
105,647
-99,618
19,454
66,820
22,545
-128,053
32,245
141,614
Deferred Taxes & Provisions
1,547
-656
1,527
-1,953
47
4,180
-2,137
-7,236
-44,009
234
3,320
46,988
-1,956
2,644
7,363
Cash flow from operations
-182,399
-289,648
358,065
398,336
-69,695
20,248
207,567
-281,018
-305,022
222,206
-21,421
346,630
43,716
162,143
1,350,460
Investing Activities
capital expenditure
-6,811
-875
-26,473
4,704
-15,386
-21,379
92,071
657,662
-92,276
-38,557
-329,845
-104,208
-135,956
-1,351,174
Change in Investments
cash flow from investments
-6,811
-875
-26,473
4,704
-15,386
-21,379
92,071
657,662
-92,276
-38,557
-329,845
-104,208
-135,956
-1,351,174
Financing Activities
Bank loans
Group/Directors Accounts
-61,397
6,564
54,833
-33,480
33,480
Other Short Term Loans
Long term loans
-37,814
37,814
-64,660
64,660
Hire Purchase and Lease Commitments
other long term liabilities
-122,236
-24,447
146,683
-12,975
-222,275
-84,291
68,487
-19,238
-138,297
408,589
share issue
100
interest
36,449
12,568
1,051
622
2,911
2,296
955
1,703
1,265
642
14
161
-657
-175
1,022
cash flow from financing
36,449
-109,668
-23,396
147,305
2,911
-59,101
7,519
56,536
-45,190
-188,153
-122,091
106,462
-84,555
-73,812
409,711
cash and cash equivalents
cash
-152,761
-400,191
308,196
550,345
-82,170
-60,232
215,085
-132,412
307,450
-58,223
-182,069
123,247
-145,047
-47,625
408,997
overdraft
change in cash
-152,761
-400,191
308,196
550,345
-82,170
-60,232
215,085
-132,412
307,450
-58,223
-182,069
123,247
-145,047
-47,625
408,997
avenue pharmacy (sunderland) limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for avenue pharmacy (sunderland) limited. Get real-time insights into avenue pharmacy (sunderland) limited's credit score, group structure and payment trends.
Perform a competitor analysis for avenue pharmacy (sunderland) limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in SR6 area or any other competitors across 12 key performance metrics.
avenue pharmacy (sunderland) limited Ownership
AVENUE PHARMACY (SUNDERLAND) LIMITED group structure
Avenue Pharmacy (Sunderland) Limited has no subsidiary companies.
The sole shareholder of Avenue Pharmacy (Sunderland) Limited is Avenue (North East) Limited.
avenue (north east) limited
100%
avenue pharmacy (sunderland) limited directors
Avenue Pharmacy (Sunderland) Limited currently has 2 directors.
The longest serving directors include
Mr Robert Burns (Jul 2002) and
Mr James Burns (Jun 2008).
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 3 charges/mortgages relating to avenue pharmacy (sunderland) limited. Currently there are 3 open charges and 0 have been satisfied in the past.
avenue pharmacy (sunderland) limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for AVENUE PHARMACY (SUNDERLAND) LIMITED. This can take several minutes, an email will notify you when this has completed.
avenue pharmacy (sunderland) limitedCompanies House Filings - See Documents
